← New search
Phenotype profile

familial hypercholesterolemia

HP:0003124 · 143890 · SaudiVarKB evidence summary derived from retained literature mentions.

155Phenotype mentions
100Publications
50Associated gene records
50Associated variant records

Associated gene records

Co-mentioned in the same publications
GeneIdentifier / contextArticlesMentions
LDLRHGNC:65474040
PCSK9HGNC:200012525
APOBHGNC:6031010
ABCG5HGNC:1388633
PAHHGNC:858222
APOEHGNC:61322
SCN5AHGNC:1059322
ACEHGNC:270722
CYP3A5HGNC:263822
LDLRAP1HGNC:1864022
PON1HGNC:920422
CYP7A1HGNC:265122
CD4HGNC:167811
ENPP1HGNC:335611
CD40HGNC:1191911
TBX4HGNC:1160311
SCN10AHGNC:1058211
TGHGNC:1176411
KCNQ1HGNC:629411
G6PDHGNC:405711
STAT3HGNC:1136411
PMP22HGNC:911811
AGLHGNC:32111
PLCG2HGNC:906611
ABCB1HGNC:4011
CYP3A4HGNC:263711
BRAFHGNC:109711
GATA2HGNC:417111
VDRHGNC:1267911
ASPMHGNC:1904811
ANGPTL3HGNC:49111
JAK2HGNC:619211
ATP8B1HGNC:370611
ABCG8HGNC:1388711
AKAP9HGNC:37911
EGFRHGNC:323611
CSNK1A1HGNC:245111
JAK3HGNC:619311
RALAHGNC:983911
ZEB2HGNC:1488111
EGFHGNC:322911
ABCA1HGNC:2911
FASHGNC:1192011
MPLHGNC:721711
GRM7HGNC:459911
CD44HGNC:168111
PRDM13HGNC:1399811
JAK1HGNC:619011
TDP1HGNC:1888411
CHD7HGNC:2062611

Associated variant records

Co-mentioned in the same publications
VariantIdentifier / contextArticlesMentions
p.W577Cp.W577C33
c.1474G>Ac.1474G>A22
p.D492Np.D492N22
c.1429G>Ac.1429G>A22
p.D477Np.D477N22
c.2027delGc.2027delG22
c.2027delc.2027del11
p.C231*p.C231*11
p.R744*p.R744*11
c.335_336insCGAGc.335_336insCGAG11
p.F114Rfsp.F114Rfs11
c.622G>Ac.622G>A11
p.E208Kp.E208K11
c.1421C>Gc.1421C>G11
p.S474*p.S474*11
p.His493Argp.His493Arg11
rs151009667rs15100966711
p.Y419Dp.Y419D11
p.S202Tfsp.S202Tfs11
rs429358rs42935811
rs7412rs741211
p.Arg987Terp.Arg987Ter11
p.Asp36Tyrp.Asp36Tyr11
p.Gly140Serp.Gly140Ser11
p.Arg284Terp.Arg284Ter11
p.Pro106Leup.Pro106Leu11
Q192RQ192R11
p.Trp577Argp.Trp577Arg11
p.Leu479Glnp.Leu479Gln11
p.Glu668*p.Glu668*11
c.1731G>Tc.1731G>T11
c.1783C>Tc.1783C>T11
p.R595Wp.R595W11
c.9835A>Gc.9835A>G11
p.S3279Gp.S3279G11
G894TG894T11
p.G676Afsp.G676Afs11
c.2026delGc.2026delG11
1171G>A1171G>A11
1167G>A1167G>A11
c.1706-1715delc.1706-1715del11
c.2416dupc.2416dup11
p.Gln35Terp.Gln35Ter11
c.2416dupGc.2416dupG11
rs2278426rs227842611
c.666_670dupc.666_670dup11
p.Ser3279Glyp.Ser3279Gly11
R496WR496W11
rs629301rs62930111
rs1367117rs136711711

Associated population records

Co-mentioned in the same publications
PopulationIdentifier / contextArticlesMentions
Saudi Arabia1818
Saudi Arabia55
Population record55
Population recordCohort 1633
Population recordCohort 322
Saudi Arabia · Riyadh22
Population recordCohort 2822
Population recordCohort 20022
Saudi ArabiaCohort 20022
Population recordCohort 95011
Population recordCohort 1911
Population recordCohort 91211
Saudi ArabiaCohort 3711
Population recordCohort 411
Saudi Arabia · JazanCohort 12311
Saudi ArabiaCohort 8811
Population recordCohort 5011
Saudi ArabiaCohort 51411
Saudi Arabia · Jeddah11
Population recordCohort 54011
Population recordCohort 19611
Saudi Arabia · RiyadhCohort 10011
Saudi ArabiaCohort 4311
Population recordCohort 3211
Saudi Arabia · HailCohort 43011
Saudi Arabia · Asir11
Saudi ArabiaCohort 12011
Saudi ArabiaCohort 10011
Population recordCohort 911
Saudi Arabia · HailCohort 111
Saudi Arabia · Qassim11
Saudi ArabiaCohort 50011
Saudi Arabia · Jazan11
Population recordCohort 61211
Saudi ArabiaCohort 36611
Saudi ArabiaCohort 2211
Population recordCohort 7911
Saudi Arabia · Hail11
Population recordCohort 75111
Population recordCohort 1,25711
Saudi ArabiaCohort 13911
Population recordCohort 8811
Saudi ArabiaCohort 911
Saudi ArabiaCohort 12811
Population recordCohort 21511
Saudi Arabia · RiyadhCohort 22511
Saudi Arabia · RiyadhCohort 1711
Saudi ArabiaCohort 9211
Saudi ArabiaCohort 25011
Saudi Arabia · RiyadhCohort 49211

Supporting publications

100 records
  1. 2026Optimizing cardiovascular health: a systematic review and meta-analysis of olezarsen dosages in high-risk hypertriglyceridemic patients.Naunyn-Schmiedeberg's archives of pharmacology1 mentions
  2. 2026Whole-exome sequencing in obstructive coronary artery disease identifies rare and novel variants in cardiac arrhythmia and pulmonary arterial hypertension-associated genes.Biomolecules & biomedicine1 mentions
  3. 2026Severe left main and ostial right coronary obstruction with supra aortic valve atherosclerotic stenosis in a 16 Year old patient with familial hypercholesterolemia: A case report.Journal of cardiovascular computed tomography1 mentions
  4. 2026Traditional cardiovascular risk factors and their association with atherosclerotic cardiovascular disease in homozygous familial hypercholesterolemia: A cross-sectional analysis from the HICC registry.Atherosclerosis1 mentions
  5. 2026Global survey of genetic testing methods for familial hypercholesterolemia. A study and recommendations from the EAS FHSC registry.European journal of preventive cardiology1 mentions
  6. 2026Homozygous familial hypercholesterolaemia: insights from the Global HICC Registry.European heart journal1 mentions
  7. 2026Investigating the phytotherapeutic efficacy of Acacia nilotica pod ethanolic extract in modulating lipid profile, oxidative stress and inflammation in diet-induced hypercholesterolemia: in vivo and in silico insights.Frontiers in pharmacology1 mentions
  8. 2026Correction: Untargeted metabolomics reveals distinct biomarkers and metabolic alterations in familial and non-genetic hypercholesterolemia in Saudi patients.Frontiers in medicine1 mentions
  9. 2026Meta-Analysis of Oral PCSK9 Inhibitors for Hypercholesterolemia in Adults: A Systematic Review and GRADE Assessment.Cardiology in review1 mentions
  10. 2026Advancing Lipid Management: Saudi Heart Association Position Statement on PCSK9-targeted Therapies in the Primary and Secondary Prevention of Cardiovascular Disease.Journal of the Saudi Heart Association1 mentions
  11. 2026Premature atherosclerotic cardiovascular disease in the MENA region: economic impact, barriers to care, and policy recommendations for an escalating crisis.Current opinion in lipidology1 mentions
  12. 2025Overweight, obesity, and cardiovascular disease in heterozygous familial hypercholesterolaemia: the EAS FH Studies Collaboration registry.European heart journal1 mentions
  13. 2025Unraveling molecular interconnections and identifying potential therapeutic targets of significance in obesity-cancer link.Journal of the National Cancer Center1 mentions
  14. 2025Familial hypercholesterolemia in pregnancy.Current opinion in lipidology1 mentions
  15. 2025Homozygous familial hypercholesterolemia evaluation and survival single center study in Saudi Arabia: The HESSA registry.Atherosclerosis1 mentions
  16. 2025Homozygous Familial Hypercholesterolemia Is a Life-Limiting Condition: Medical Life-Trajectories in the Post-2010 Era.Journal of the American College of Cardiology1 mentions
  17. 2025Long noncoding RNAs in familial hypercholesterolemia: biomarkers, therapeutics, and AI in precision medicine.Lipids in health and disease1 mentions
  18. 2025The Prevalence and Predictors of Sickle Cell Anemia in the Saudi Arabia General Population: Findings from a Cross-Sectional Study.Healthcare (Basel, Switzerland)1 mentions
  19. 2025Prevalence of very high cholesterol levels in asymptomatic military recruits: A single center study.Saudi medical journal1 mentions
  20. 2025Unlocking the potential: advancements and applications of gene therapy in severe disorders.Annals of medicine1 mentions
  21. 2025Homozygous familial hypercholesterolemia in a high-consanguinity population: Insights from a Saudi cohort.Journal of clinical lipidology1 mentions
  22. 2025Gastric mucosal differentially expressed genes after bariatric surgery: Effects on sterol-related pathways.The Journal of steroid biochemistry and molecular biology1 mentions
  23. 2025Assessment of Primary Health Care Physicians' Awareness, Knowledge, and Practice of Familial Hypercholesterolemia in Jazan, Saudi Arabia.Cureus1 mentions
  24. 2025Multimodal Therapy Achieves Secondary Prevention LDL-C Targets in LDL-Receptor Null Homozygous Familial Hypercholesterolemia.JACC. Case reports1 mentions
  25. 2025Pathogenic LDLR Variants (c.103 C>T and c.2416dup) in ligand-binding and cytosolic domains in Saudi familial hypercholesterolemia: Molecular characterization and computational insights.Computational and structural biotechnology journal1 mentions
  26. 2025Flaxseed in Diabetes Management: Nutritional and Therapeutic Insights.Current nutrition reports1 mentions
  27. 2025Untargeted metabolomics reveals distinct biomarkers and metabolic alterations in familial and non-genetic hypercholesterolemia in Saudi patients.Frontiers in medicine1 mentions
  28. 2025Medical and Financial Consequences of Using PCSK9 Inhibitors for Managing Hypercholesterolemia in Saudi Arabia: A Historical Cohort Study.Healthcare (Basel, Switzerland)1 mentions
  29. 2025Whole exome sequencing identifies concurrent LDLR and ABCG8 mutations in a Saudi family with familial hypercholesterolemia and Sitosterolaemia.Frontiers in genetics1 mentions
  30. 2025Fair pricing, fair access; a systematic review of cost-effectiveness of new hyperlipidemia injectable medication in developing countries.Cost effectiveness and resource allocation : C/E1 mentions
  31. 2024Modern approaches to the management of homozygous familial hypercholesterolemia in the Middle East and North Africa.Journal of clinical lipidology1 mentions
  32. 2024The Effect of PCSK9 Inhibitors on LDL-C Target Achievement in Patients with Homozygous Familial Hypercholesterolemia: A Retrospective Cohort Analysis.Advances in therapy1 mentions
  33. 2024Knowledge, attitude, and practice of physicians towards familial hypercholesterolaemia in north regions of Saudi Arabia.JPMA. The Journal of the Pakistan Medical Association1 mentions
  34. 2024Berberine attenuates inflammation and oxidative stress and modulates lymphocyte E-NTPDase in acute hyperlipidemia.Drug development research1 mentions
  35. 2024Correction to: The Effect of PCSK9 Inhibitors on LDL-C Target Achievement in Patients with Homozygous Familial Hypercholesterolemia: A Retrospective Cohort Analysis.Advances in therapy1 mentions
  36. 2024Addressing comprehensive complexities a striking familial hypercholesterolemia case study.The Egyptian heart journal : (EHJ) : official bulletin of the Egyptian Society of Cardiology1 mentions
  37. 2024Association between genetic variants of GRM7 (rs1396409 and rs9883258) and treatment outcomes in Schizophrenic Egyptian patients.Nucleosides, nucleotides & nucleic acids1 mentions
  38. 2024Lomitapide: A Medication Use Evaluation and a Formulary Perspective.Global journal on quality and safety in healthcare1 mentions
  39. 2024Potentials of artificial intelligence in familial hypercholesterolemia: Advances in screening, diagnosis, and risk stratification for early intervention and treatment.International journal of cardiology1 mentions
  40. 2024Sucralose Influences the Productive Performance, Carcass Traits, Blood Components, and Gut Microflora Using 16S rRNA Sequencing of Growing APRI-Line Rabbits.Animals : an open access journal from MDPI1 mentions
  41. 2024Sitosterolemia With Two Heterozygous Variants Including a Novel Mutation c.1800T>A in the ABCG5 Gene: A Case Report of a Rare Condition in a Young Saudi Girl.Cureus1 mentions
  42. 2024Use and effectiveness of PCSK-9 inhibitors in heart diseases: A review.Medicine1 mentions
  43. 2024Lomitapide for the treatment of paediatric patients with homozygous familial hypercholesterolaemia (APH-19): results from the efficacy phase of an open-label, multicentre, phase 3 study.The lancet. Diabetes & endocrinology1 mentions
  44. 2024The effectiveness of liver transplantation in reducing lipid levels in Saudi children with homozygous familial hypercholesterolemia.Frontiers in cardiovascular medicine1 mentions
  45. 2024Prognostic Value of Normal Triglyceride Levels among Patients with Target Low-density Lipoproteins Presenting with First Acute Coronary Syndrome.Heart views : the official journal of the Gulf Heart Association1 mentions
  46. 2023Identification and functional characterization of two rare LDLR stop gain variants (p.C231* and p.R744*) in Saudi familial hypercholesterolemia patients.Panminerva medica1 mentions
  47. 2023Association of CELSR2, APOB100, ABCG5/8, LDLR, and APOE polymorphisms and their genetic risks with lipids among the Thai subjects.Saudi journal of biological sciences1 mentions
  48. 2023Management and clinical outcomes of patients with homozygous familial hypercholesteremia in Saudi Arabia.Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace1 mentions
  49. 2023Apigenin ameliorates hypercholesterolemic-induced kidney injury via modulating renal KIM-1, Fn1, and Nrf2 signaling pathways.European review for medical and pharmacological sciences1 mentions
  50. 2023Various Expressions of PIK3C2A and TXNIP Genes and Their Potential Role as Independent Risk Factors for Chronic Stable Angina and Acute Coronary Syndrome.Biomolecules1 mentions
  51. 2023Exploring the Sociodemographic and Behavioral Status of People Living with Hypercholesterolemia in Saudi Arabia: A Nation-Wide Cross-Sectional Study.Risk management and healthcare policy1 mentions
  52. 2023Protein structural insights into a rare PCSK9 gain-of-function variant (R496W) causing familial hypercholesterolemia in a Saudi family: whole exome sequencing and computational analysis.Frontiers in physiology1 mentions
  53. 2023Novel LDLR Variant in Familial Hypercholesterolemia: NGS-Based Identification, In Silico Characterization, and Pharmacogenetic Insights.Life (Basel, Switzerland)1 mentions
  54. 2023Physicians' perceptions and beliefs on the current dyslipidemia management practices within Saudi Arabia.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society1 mentions
  55. 2023Real-World Insights into Evolocumab Use in Patients with Hyperlipidemia Across Five Countries: Analysis from the ZERBINI Study.Cardiology and therapy1 mentions
  56. 2023Genetic association between vitamin D receptor gene and Saudi patients confirmed with Familial Hypercholesterolemia.Acta biochimica Polonica1 mentions
  57. 2022Cost-Effectiveness Analysis of Evolocumab for the Treatment of Dyslipidemia in the Kingdom of Saudi Arabia.PharmacoEconomics - open1 mentions
  58. 2022Consensus clinical recommendations for the management of plasma lipid disorders in the Middle East: 2021 update.Atherosclerosis1 mentions
  59. 2022Identification of Novel and Known LDLR Variants Triggering Severe Familial Hypercholesterolemia in Saudi Families.Current vascular pharmacology1 mentions
  60. 2022Is Liver Transplant Curative in Homozygous Familial Hypercholesterolemia? A Review of Nine Global Cases.Advances in therapy1 mentions
  61. 2022Gaps in knowledge and practice for familial hypercholesterolemia among physicians caring for children in Saudi Arabia.European review for medical and pharmacological sciences1 mentions
  62. 2022Edible Bird's Nest Regulates Hepatic Cholesterol Metabolism through Transcriptional Regulation of Cholesterol Related Genes.Evidence-based complementary and alternative medicine : eCAM1 mentions
  63. 2022Association of cytochromes P450 3A4*22 and 3A5*3 genotypes and polymorphism with response to simvastatin in hypercholesterolemia patients.PloS one1 mentions
  64. 2022Identifying significant genes and functionally enriched pathways in familial hypercholesterolemia using integrated gene co-expression network analysis.Saudi journal of biological sciences1 mentions
  65. 2022Ataxia with oculomotor apraxia type 1 associated with mutation in the APTX gene: A case study and literature review.Experimental and therapeutic medicine1 mentions
  66. 2022Lycopene Modulates Oxidative Stress and Inflammation in Hypercholesterolemic Rats.Pharmaceuticals (Basel, Switzerland)1 mentions
  67. 2022New Trends and Therapies for Familial Hypercholesterolemia.Journal of clinical medicine1 mentions
  68. 2022Exome Sequencing Revealed a Novel Splice Site Variant in the CRB2 Gene Underlying Nephrotic Syndrome.Medicina (Kaunas, Lithuania)1 mentions
  69. 2021Dietary Recommendations for Familial Hypercholesterolaemia: an Evidence-Free Zone.BMJ evidence-based medicine1 mentions
  70. 2021Coronary artery disease in patients with human immunodeficiency virus infection.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology1 mentions
  71. 2021LDL cholesterol promotes the proliferation of prostate and pancreatic cancer cells by activating the STAT3 pathway.Journal of cellular physiology1 mentions
  72. 2021Late outcomes in survivors of childhood acute myeloid leukemia: a report from the St. Jude Lifetime Cohort Study.Leukemia1 mentions
  73. 2021Homozygous Familial Hypercholesterolemia (HoFH) in Saudi Arabia and Two Cases of Lomitapide Use in a Real-World Setting.Advances in therapy1 mentions
  74. 2021Familial Hypercholesterolemia in the Arabian Gulf Region: Clinical results of the Gulf FH Registry.PloS one1 mentions
  75. 2021Saudi Familial Hypercholesterolemia Patients With Rare LDLR Stop Gain Variant Showed Variable Clinical Phenotype and Resistance to Multiple Drug Regimen.Frontiers in medicine1 mentions
  76. 2021Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC).Lancet (London, England)1 mentions
  77. 2020The Gulf Familial Hypercholesterolemia Registry (Gulf FH): Design, Rationale and Preliminary Results.Current vascular pharmacology1 mentions
  78. 2020Molecular insights into the coding region mutations of low-density lipoprotein receptor adaptor protein 1 (LDLRAP1) linked to familial hypercholesterolemia.The journal of gene medicine1 mentions
  79. 2020Practice of lipoprotein apheresis and short-term efficacy in children with homozygous familial hypercholesterolemia: Data from an international registry.Atherosclerosis1 mentions
  80. 2020Breast arterial calcification on mammography does not predict coronary artery disease by invasive coronary angiography.Annals of Saudi medicine1 mentions
  81. 2020Association of ANGPTL8 (Betatrophin) Gene Variants with Components of Metabolic Syndrome in Arab Adults.Scientific reports1 mentions
  82. 2020Insights into pharmacological mechanisms of polydatin in targeting risk factors-mediated atherosclerosis.Life sciences1 mentions
  83. 2020Assessment of medical intern's knowledge, awareness and practice of familial hypercholesterolemia at academic institutes in Jeddah, Saudi Arabia.Lipids in health and disease1 mentions
  84. 2020Lomitapide for treatment of homozygous familial hypercholesterolemia: The Québec experience.Atherosclerosis1 mentions
  85. 2019Screening of common genetic variants in the APOB gene related to familial hypercholesterolemia in a Saudi population: A case-control study.Medicine1 mentions
  86. 2019Recently reported familial hypercholesterolemia-related mutations from cases in the Middle East and North Africa region.Current opinion in lipidology1 mentions
  87. 2019Impact of Age on the Efficacy and Safety of Alirocumab in Patients with Heterozygous Familial Hypercholesterolemia.Cardiovascular drugs and therapy1 mentions
  88. 2019Genetic testing for familial hypercholesterolemia: Impact on diagnosis, treatment and cardiovascular risk.European journal of preventive cardiology1 mentions
  89. 2019Modifying inter-cistronic sequence significantly enhances IRES dependent second gene expression in bicistronic vector: Construction of optimised cassette for gene therapy of familial hypercholesterolemia.Non-coding RNA research1 mentions
  90. 2019Spinocerebellar ataxia with axonal neuropathy type 1 revisited.Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia1 mentions
  91. 2019A short review of proprotein convertase subtilisin/kexin type 9 inhibitors.Reviews in cardiovascular medicine1 mentions
  92. 2019Genetic Risk Score for Coronary Disease Identifies Predispositions to Cardiovascular and Noncardiovascular Diseases.Journal of the American College of Cardiology1 mentions
  93. 2019PCSK9 and inflammation: a review of experimental and clinical evidence.European heart journal. Cardiovascular pharmacotherapy1 mentions
  94. 2019LDLR Gene Polymorphisms (rs5925 and rs1529729) Are Associated with Susceptibility to Coronary Artery Disease in a South Indian Population.Medical sciences (Basel, Switzerland)1 mentions
  95. 2019Assessment of family physicians' awareness and knowledge of familial hypercholesterolemia in governmental hospitals in Riyadh, Saudi Arabia.Journal of family medicine and primary care1 mentions
  96. 2019Treatment effect of alirocumab according to age group, smoking status, and hypertension: Pooled analysis from 10 randomized ODYSSEY studies.Journal of clinical lipidology1 mentions
  97. 2019Familial hypercholesterolemia with bilateral cholesterol granuloma: A case series.International journal of surgery case reports1 mentions
  98. 2019Molecular Dynamics Simulation Reveals Exposed Residues in the Ligand-Binding Domain of the Low-Density Lipoprotein Receptor that Interacts with Vesicular Stomatitis Virus-G Envelope.Viruses1 mentions
  99. 2018In Silico Approach to Investigate the Structural and Functional Attributes of Familial Hypercholesterolemia Variants Reported in the Saudi Population.Journal of computational biology : a journal of computational molecular cell biology1 mentions
  100. 2018Prevalence, management, and outcomes of familial hypercholesterolemia in patients with acute coronary syndromes in the Arabian Gulf.Journal of clinical lipidology1 mentions